Dolby Laboratories, Inc. (DLB) Presents at 46th Annual William Blair Growth Stock Conference Transcript
Dolby Labs is rated a 'BUY' with a conservative $80/share price target, reflecting 17–25% annualized upside potential through 2028. DLB trades at a rare sub-15x P/E, supported by robust patent-driven recurring revenue, high margins, and a net cash balance exceeding $500M. Despite cyclical end-market exposure and recent earnings volatility, DLB's technology leadership and dominant licensing position underpin long-term revenue security.
DLB beats Q2 estimates as licensing growth, strong broadcast demand and expanding Dolby Atmos adoption drive revenue and a steady outlook.
Dolby Laboratories, Inc. (DLB) Q2 2026 Earnings Call Transcript
The headline numbers for Dolby Laboratories (DLB) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Dolby Laboratories (DLB) came out with quarterly earnings of $1.37 per share, beating the Zacks Consensus Estimate of $1.31 per share. This compares to earnings of $1.34 per share a year ago.
Dolby Laboratories (DLB) offers a compelling risk-reward profile with high margins, robust free cash flow, and a reasonable valuation. DLB's intrinsic value is estimated near $80 per share, implying 36% upside from current levels and supporting a double-digit annual return outlook. Growth is driven by expanding automotive, mobile, and streaming partnerships, with 93% of sales from licensing and strong IP protection.
Investments in cutting-edge and innovative solutions are likely to aid Zacks Audio Video Production industry participants like DLB, SONO and LVO amid cautious discretionary spending.
Dynamic Technology Lab Private Ltd reduced its position in shares of Dolby Laboratories (NYSE: DLB) by 79.5% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,791 shares of the electronics maker's stock after selling 14,739
The average of price targets set by Wall Street analysts indicates a potential upside of 40.2% in Dolby Laboratories (DLB). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
The average of price targets set by Wall Street analysts indicates a potential upside of 39% in Dolby Laboratories (DLB). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
DLB beats Q1 EPS and revenue estimates, but sales fall year over year on weaker licensing, sending shares down about 3% after hours.